Accelerating Growth in Biomedical and Emerging Technologies
Zim Corporation accelerates research and growth in biomedical and emerging technology companies. Our obsession with disruptive technologies drives our curiosity to research emerging tech markets and recognize industry trends. We have the knowledge and experience to apply winning strategies from research to commercialization of products across multiple industries.
NuvoBio is a wholly owned subsidiary of Zim Corporation focused on developing intellectual property and advancing research and development in the areas of new synthetic drugs and Immunotherapies.
Zim Corporation accelerates research and growth in biomedical and emerging technology companies.
Zim in the News
Read the latest news and information about Zim Corporation, from investments to research and company headlines.
We have been around a while. A core leadership group spanning multiple technology industries with more than 40 years of investing, building and operating enterprise hardware, software and emerging technology companies, we know what it takes to build a successful business. We roll up our sleeves and develop a deep understanding of the sectors that we work in. We are passionate about the iterative process of developing, building & executing with other entrepreneurs and technology leaders. We dedicate our time and resources to accelerating research and while seeking markets to capture opportunity, and realize value.
For more information:
ZIM Corporate Headquarters
150 Isabella Street, Suite 150
Canada K1S 1V7